Tuesday, August 5, 2025
Science
No Result
View All Result
  • Login
  • HOME
  • SCIENCE NEWS
  • CONTACT US
  • HOME
  • SCIENCE NEWS
  • CONTACT US
No Result
View All Result
Scienmag
No Result
View All Result
Home Science News Technology and Engineering

C-Path inaugural Global Impact Conference: Pioneering drug development collaborations

August 8, 2024
in Technology and Engineering
Reading Time: 3 mins read
0
C-Path inaugural Global Impact Conference: Pioneering drug development collaborations
65
SHARES
594
VIEWS
Share on FacebookShare on Twitter
ADVERTISEMENT

TUCSON, Ariz., August 7, 2024 – Critical Path Institute (C-Path), whose mission is to lead collaborations that accelerate drug development, advancing better treatments for people worldwide, is proud to announce its inaugural C-Path Global Impact Conference (CGIC), taking place from September 9-11, 2024, at the Washington Marriott at Metro Center. 

TUCSON, Ariz., August 7, 2024 – Critical Path Institute (C-Path), whose mission is to lead collaborations that accelerate drug development, advancing better treatments for people worldwide, is proud to announce its inaugural C-Path Global Impact Conference (CGIC), taking place from September 9-11, 2024, at the Washington Marriott at Metro Center. 

ADVERTISEMENT

The conference represents a significant expansion of C-Path’s mission, focusing on critical areas of drug development. These areas highlight how C-Path’s areas of core excellence — data management and standards, biomarkers, modeling and analytics, regulatory science, and clinical outcome assessments — interlink across all stages of drug development, demonstrating the value of C-Path’s public-private partnership model. By bringing together industry leaders, regulatory agencies, academic researchers, and patient advocates, the conference will incubate productive dialogues addressing the challenges and opportunities within drug development.

C-Path is also excited to confirm the participation of key leaders from the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) throughout the three-day conference. Leading figures from both regulatory bodies will serve as in-person panelists, contributing their expertise to diverse discussions. Their active roles offer attendees a unique opportunity to gain firsthand knowledge and actionable guidance from regulatory experts at the forefront of drug development.

Klaus Romero, M.D., M.S., FCP, CEO of C-Path, expressed his enthusiasm for the first-of-its-kind conference, stating, “CGIC serves as a crucial forum for stakeholders from across the drug development landscape to share insights, strategies, and innovations. Our goal is to drive discussions that will lead to actionable solutions for accelerating the availability of therapies for individuals and families worldwide. Put simply, CGIC is the conference that drug developers cannot afford to miss.”

The event will feature a series of presentations and panel discussions designed to spark innovation and promote the sharing— and alignment — of best practices and solutions to accelerate drug development. Attendees will have the opportunity to engage in in-depth discussions on integrating insights across therapeutic areas, navigating regulatory landscapes, and harnessing novel technologies in drug development.

The conference will also highlight the power of public-private partnerships in advancing drug development and regulatory science, demonstrating how collaborative approaches can lead to breakthroughs in treatment discovery and development.

Registration for the CGIC is now open. For more information about the conference and to register, please visit: https://web.cvent.com/event/e25a101c-7408-4295-b318-4073790c6f27/summary.

About Critical Path Institute

Critical Path Institute (C-Path) is an independent, nonprofit organization established in 2005 as a public and private partnership. C-Path’s mission is to catalyze the development of new approaches that advance medical innovation and regulatory science, accelerating the path to a healthier world. An international leader in forming collaborations, C-Path has established numerous global consortia that currently include more than 1,600 scientists from government and regulatory agencies, academia, patient organizations, disease foundations, and hundreds of pharmaceutical and biotech companies. C-Path U.S. is headquartered in Tucson, Arizona and C-Path in Europe is headquartered in Amsterdam, Netherlands with additional staff in multiple other locations. For more information, visit c-path.org.

Critical Path Institute is supported by the Food and Drug Administration (FDA) of the Department of Health and Human Services (HHS) and is 55% funded by the FDA/HHS, totaling $17,612,250, and 45% funded by non-government source(s), totaling $14,203,111. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, FDA/HHS or the U.S. Government.

Media Contacts: 

Roxan Triolo Olivas
C-Path
520.954.1634
rolivas@c-path.org

Kissy Black
C-Path
615.310.1894
kblack@c-path.org



Share26Tweet16
Previous Post

Skin-to-skin ‘kangaroo care’ found to boost neurodevelopment in preemies

Next Post

Molecule restores cognition, memory in Alzheimer’s disease model mice

Related Posts

blank
Technology and Engineering

Uncertainty-Aware Breakthrough in Fourier Ptychography

August 5, 2025
blank
Technology and Engineering

Nano vs. Micro Plastics Impact on Live Algae

August 5, 2025
blank
Technology and Engineering

Scaling Biocarbon Supercapacitors: Evaluating Performance and Resistance

August 5, 2025
blank
Technology and Engineering

PeroCycle Appoints New CEO and Launches £4M Seed Round to Advance Decarbonization in Steelmaking

August 5, 2025
blank
Technology and Engineering

Getting Reliable Expert Probabilities for Risk Analysis

August 5, 2025
blank
Technology and Engineering

Microplastics in Indo-Sri Lankan Freshwater Sediments Reviewed

August 5, 2025
Next Post
Molecule restores cognition, memory in Alzheimer’s disease model mice

Molecule restores cognition, memory in Alzheimer’s disease model mice

  • Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    27529 shares
    Share 11008 Tweet 6880
  • University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept

    939 shares
    Share 376 Tweet 235
  • Bee body mass, pathogens and local climate influence heat tolerance

    640 shares
    Share 256 Tweet 160
  • Researchers record first-ever images and data of a shark experiencing a boat strike

    506 shares
    Share 202 Tweet 127
  • Warm seawater speeding up melting of ‘Doomsday Glacier,’ scientists warn

    310 shares
    Share 124 Tweet 78
Science

Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!

RECENT NEWS

  • Anti-AMPAR Encephalitis Manifests as Catatonia
  • AI Predicts Gastric Cancer Outcomes via CEA
  • Uncertainty-Aware Breakthrough in Fourier Ptychography
  • Virus Remodels Genome, Hijacks KDM5B to Drive Metastasis

Categories

  • Agriculture
  • Anthropology
  • Archaeology
  • Athmospheric
  • Biology
  • Bussines
  • Cancer
  • Chemistry
  • Climate
  • Earth Science
  • Marine
  • Mathematics
  • Medicine
  • Pediatry
  • Policy
  • Psychology & Psychiatry
  • Science Education
  • Social Science
  • Space
  • Technology and Engineering

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 5,184 other subscribers

© 2025 Scienmag - Science Magazine

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • HOME
  • SCIENCE NEWS
  • CONTACT US

© 2025 Scienmag - Science Magazine

Discover more from Science

Subscribe now to keep reading and get access to the full archive.

Continue reading